May 12, 2026 4:15pm EDT DiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 06, 2026 4:30pm EDT DiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
Apr 30, 2026 8:25am EDT DiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
Mar 30, 2026 4:45pm EDT DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
Mar 23, 2026 8:25am EDT DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
Mar 05, 2026 7:35am EST DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
Dec 18, 2025 8:45am EST DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
Nov 12, 2025 4:30pm EST DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
